IP Library Granted Patent US 9,512,489
Granted Patent B2
US 9,512,489 · App. 14/399,954 · Granted Dec 6, 2016

Method for detecting genes sensitive to low-level ionizing radiation

Inventors: Hee Sun Kim (Uijeongbu, KR); Seung Jin Choi (Seoul, KR); Moo Hyun Choi (Seoul, KR); Jin Jong Bong (Seoul, KR); Seok Cheol Shin (Seoul, KR)
Assignee: KOREA HYDRO & NUCLEAR POWER CO., LTD.
C12Q1/6886C12Q1/6883C12Q2600/112C12Q2600/158C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,512,489
App. No.
14/399,954
Granted
Dec 6, 2016
Kind
B2
Abstract

A method for detecting genes sensitive to low-level ionizing radiation and genes detected by the method. More specifically, genes sensitive to low-level ionizing radiation, discovered in a carcinogenic entity and verified in a normal entity are detected by subjecting a cancerous AKR/J mouse and a normal ICR mouse to low-level radiation. Thymus is collected therefrom, and glycometabolism-related genes are classified via microarray processing of the thymus. The genes are amplified and the levels of gene expression are measured. Thus, a gene having a specific reaction to radiation can be accurately detected by preventing the interference of confounding variables.

Claims (9)

1. A method for detecting a gene sensitive to an ionizing radiation, the method comprising the steps of:

irradiating a cancer-induced AKR/J mouse and an ICR mouse with a gamma radiation at a dose rate of a dose rate of 0.7 mGy/hr to a final dose of 1.7 Gy;

extracting thymi from the AKR/J mouse and the ICR mouse;

subjecting the thymi to a microarray analysis;

selecting a G6pc gene as a glucose metabolism-related gene from the microarray analysis; and

amplifying the G6pc gene and measuring an expression level of the gene.

2. The method of claim 1 , wherein the cancer is thymic cancer.

3. The method of claim 1 , further comprising the step of extracting the thymi at a time point when the mouse starts to die of the cancer.

4. The method of claim 1 , wherein the step of amplifying the G6pc gene uses primers having sequences set forth in SEQ ID NOS: 9 and 10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2015
From: KIM, HEE SUN; CHOI, SEUNG JIN; CHOI, MOO HYUN; BONG, JIN JONG; SHIN, SEOK CHEOL
To: KOREA HYDRO & NUCLEAR POWER CO., LTD.
Reel/Frame 034806/0743 →
Priority Claims (1)
KR 10-2012-0049544 · May 10, 2012 · national
Continuity (1)
Related Publication 20150159219A1 · Jun 11, 2015